[go: up one dir, main page]

ES8101583A1 - A PROCEDURE FOR THE PREPARATION OF A QUINAZOLINE - Google Patents

A PROCEDURE FOR THE PREPARATION OF A QUINAZOLINE

Info

Publication number
ES8101583A1
ES8101583A1 ES488129A ES488129A ES8101583A1 ES 8101583 A1 ES8101583 A1 ES 8101583A1 ES 488129 A ES488129 A ES 488129A ES 488129 A ES488129 A ES 488129A ES 8101583 A1 ES8101583 A1 ES 8101583A1
Authority
ES
Spain
Prior art keywords
alkyl
quinazoline
substd
halo
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488129A
Other languages
Spanish (es)
Other versions
ES488129A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES488129A0 publication Critical patent/ES488129A0/en
Publication of ES8101583A1 publication Critical patent/ES8101583A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Quinazoline derivs. of formula (I) and their pharmaceutically acceptable acid addition salts are new. In (I) R = 1-4 C alkyl, benzyl or (3-6C cycloalkyl)-methyl R1=1-4C alkyl X is CH2CH2 substd. by one phenyl and opt. by 1 or 2 methyl R2 = H, 1-4C alkyl or is phenyl opt. substd. by 1 or 2, 1-4C alkyl or alkoxy, halo, CR3, CONR3R4 or SO2N-R3R4. R3 and R4 = H or 1-4C alkyl. (I) are prepd. e.g. from the corresp. 2-halo-quinazoline and appropriate 4-substd. piperidine. (I) are regulators of the cardiovascular system and are esp. useful for treating hypertension in animals and humans. The usual oral dose is 1-50 mg/day for a 70 kg adult and the intravenous dose is 10-20% of the oral dose.
ES488129A 1979-01-31 1980-01-31 A PROCEDURE FOR THE PREPARATION OF A QUINAZOLINE Expired ES8101583A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7903398 1979-01-31

Publications (2)

Publication Number Publication Date
ES488129A0 ES488129A0 (en) 1980-12-16
ES8101583A1 true ES8101583A1 (en) 1980-12-16

Family

ID=10502852

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488129A Expired ES8101583A1 (en) 1979-01-31 1980-01-31 A PROCEDURE FOR THE PREPARATION OF A QUINAZOLINE

Country Status (28)

Country Link
JP (1) JPS55104278A (en)
AR (1) AR222208A1 (en)
AT (1) AT373595B (en)
BE (1) BE881448A (en)
CA (1) CA1131636A (en)
CS (1) CS231970B2 (en)
DD (1) DD148720A5 (en)
DE (1) DE3003323A1 (en)
DK (1) DK540879A (en)
ES (1) ES8101583A1 (en)
FI (1) FI63936C (en)
FR (1) FR2447919A1 (en)
GR (1) GR73626B (en)
HU (1) HU184233B (en)
IE (1) IE800178L (en)
IL (1) IL59252A (en)
IT (1) IT1149902B (en)
LU (1) LU82115A1 (en)
NL (1) NL8000571A (en)
NO (1) NO800230L (en)
NZ (1) NZ192744A (en)
PH (1) PH15436A (en)
PL (1) PL121890B1 (en)
PT (1) PT70749A (en)
SE (1) SE8000699L (en)
SU (1) SU895291A3 (en)
YU (1) YU22980A (en)
ZA (1) ZA80557B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483920A1 (en) * 1980-06-09 1981-12-11 Synthelabo Antihypertensive piperidino quinazoline(s) - prepd. from benzyloxy piperidine and a 2:halo-4:amino 6,7-di:methoxy quinazoline
ES515338A0 (en) * 1981-09-09 1983-11-01 Orion Yhtymae Oy "METHOD FOR THE PREPARATION OF SUBSTITUTED PIPERIDINYLQUINAZOLIDINES".
US5280032A (en) * 1989-02-14 1994-01-18 Toyama Chemical Co., Ltd. 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
WO2013070852A2 (en) * 2011-11-08 2013-05-16 Emory University Compounds and compositions used to epigenetically transform cells and methods related thereto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088068A (en) * 1977-11-16 1980-10-21 Simon F. Campbell Piperidino-quinazolines
GB2021108B (en) * 1978-05-18 1982-07-21 Pfizer Ltd 6,7 - di - 4 - amino - 2 - quinazolines

Also Published As

Publication number Publication date
FR2447919A1 (en) 1980-08-29
BE881448A (en) 1980-07-30
YU22980A (en) 1983-02-28
ATA46980A (en) 1983-06-15
LU82115A1 (en) 1980-04-23
IT1149902B (en) 1986-12-10
DK540879A (en) 1980-08-01
ZA80557B (en) 1981-08-26
PT70749A (en) 1980-02-01
GR73626B (en) 1984-03-26
DD148720A5 (en) 1981-06-10
HU184233B (en) 1984-07-30
CS60780A2 (en) 1984-01-16
CA1131636A (en) 1982-09-14
CS231970B2 (en) 1985-01-16
ES488129A0 (en) 1980-12-16
FI800252A7 (en) 1980-08-01
AU5502480A (en) 1980-08-07
PL121890B1 (en) 1982-06-30
NZ192744A (en) 1984-03-30
SE8000699L (en) 1980-08-01
AR222208A1 (en) 1981-04-30
JPS5728711B2 (en) 1982-06-18
SU895291A3 (en) 1981-12-30
FI63936B (en) 1983-05-31
NO800230L (en) 1980-08-01
JPS55104278A (en) 1980-08-09
FI63936C (en) 1983-09-12
IL59252A (en) 1983-11-30
DE3003323A1 (en) 1980-08-14
PL221683A1 (en) 1980-12-01
NL8000571A (en) 1980-08-04
AT373595B (en) 1984-02-10
IE800178L (en) 1980-07-31
PH15436A (en) 1983-01-18
FR2447919B1 (en) 1983-02-11
IL59252A0 (en) 1980-05-30
IT8019537A0 (en) 1980-01-29

Similar Documents

Publication Publication Date Title
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
DK436289A (en) CYCLOALKYL-SUBSTITUTED GLUTARAMIDE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS, RELATIONSHIPS FOR MEDICAL USE AND THEIR USE FOR THE PREPARATION OF MEDICINAL PRODUCTS OR HANDLING PREPARATIONS
ES538418A0 (en) A DERIVATIVE OF INDOL-3-CARBOXAMIDE
ES549542A0 (en) A PROCEDURE FOR PREPARING NEW DERIVATIVES OF BENZO- TRIAZOL- AND BENZOXAZOLAMINE
UA27749C2 (en) Substituted cyclopropylamino-1,3,5-triazines, enantiomers, racemic mixtures or non-toxic, pharmaceutically acceptable acid addition salts thereof possessing pharmacological activity and process for the preparation thereof
DE69716810D1 (en) 2,3-disubstituted-(5,6) -heteroarylkondensierte-pyrimidin-4-one
PT76450B (en) SPIRO / 4. (3 + N) -2-AZA-3-CARBOXYLIC ACID DERIVATIVES METHOD FOR THE PRODUCTION THEREOF AND THEIR USE THEREOF
NO942952D0 (en) 11-benzaldoxyn-17 aters, a process for their preparation and a medicament containing such
ES2058173T3 (en) DIOXIALQUILENARIL-DIHIDROPIRIDINAS, INTERMEDIATE PRODUCTS FOR ITS MANUFACTURE, PROCEDURES FOR ITS MANUFACTURE AND ITS USE.
EP0152273A3 (en) A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use
ES497382A0 (en) A PROCEDURE FOR THE PREPARATION OF ACIDS 6- (1-HIDROXIETIL) -2-2 (2-AMINOETILTIO) -1-CARBADETIAPEN-2-EM-3-CARBOXILICOS1,1-DI-SUBSTITUTED.
GB1086192A (en) Phenylcyclopropane derivatives
PT77231A (en) Process for the preparation of 2-nitro-1,1-ethenediamines having a hypotensive effect and their use for the preparation of pharmaceutical compositions with a hypotensive effect
ES8101583A1 (en) A PROCEDURE FOR THE PREPARATION OF A QUINAZOLINE
ATE24509T1 (en) TRIAZOLOQUINAZOLONE AND THEIR SALTS, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR MANUFACTURE, THEIR USE AS MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THEM.
PT93450A (en) METHOD FOR PREPARING NEW AZETIDINIC DERIVATIVES OF PYRIDINOCARBOXYL ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO852514L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 8-ALKYLTIO-2-PIPERAZINO-PYRIMIDO (5,4-D) PYRIMIDINE DERIVATIVES.
NO178025C (en) Analogous Process for Preparation of Therapeutically Active (Benzhydryloxyethylpiperidyl) Aliphatic Acid Derivatives
ATE149165T1 (en) BIZYCLIC DERIVATIVES CONTAINING NITROGEN, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
OA09027A (en) Inhibition method. a virus
NO853782L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FUROPYRIDINE DERIVATIVES.
ATE32720T1 (en) 1,3,4,6,7,11B-HEXAHYDRO-7-ARYL-2H-PYRAZINO(2,1ALPHA)ISOCHINOLINES USED AS INTERMEDIATE PRODUCTS AND AS PHARMACEUTICAL COMPOUNDS AND METHOD FOR THEIR PRODUCTION.
ATE4211T1 (en) TRIAZOLOCHINAZOLINONE DERIVATIVES AND THEIR SALTS WITH THE ACIDS, THEIR MANUFACTURE, THEIR USE AS MEDICINAL PRODUCTS AND THE COMPOSITIONS CONTAINING THEM.
ES8605269A1 (en) Thiadiazole derivatives active on the central nervous system, process for their preparation and pharmaceutical compositions containing them.
AU7532787A (en) New derivatives of 2,6-piperazinedione, their preparation process and the pharmaceutical compositions containing them